Effect of atrial natriuretic peptide on adrenal renin and aldosterone

Endocrinol Jpn. 1990 Feb;37(1):47-52. doi: 10.1507/endocrj1954.37.47.

Abstract

The effect of atrial natriuretic peptide (ANP) on adrenal renin and aldosterone was investigated in anesthetized rats. Under pentobarbital anesthesia 40 mg/kg), intravenous infusion of ANP (0.25 micrograms/kg/min) for 45 min failed to alter the adrenal renin, adrenal aldosterone, and plasma aldosterone (PA). In this condition, intraperitoneal injection of ACTH (10 micrograms/kg) significantly increased the adrenal renin (from 2.4 +/- 0.1 to 5.0 +/- 0.08 ng/mg protein/h, P less than 0.05), adrenal aldosterone (from 13.6 +/- 1.3 to 22.7 +/- 2.3 ng/mg protein, P less than 0.01) and PA (from 59.8 +/- 5.8 to 75.5 +/- 7.4 ng/dl, P less than 0.05), respectively. Under ACTH stimulation, ANP infusion induced significant decreases in adrenal renin (from 5.0 +/- 0.08 to 2.8 +/- 0.2 ng/mg protein/h, P less than 0.05), adrenal aldosterone (from 22.7 +/- 2.3 to 16.2 +/- 1.8 ng/mg protein, P less than 0.05) and PA (from 75.5 +/- 7.4 to 61.6 +/- 4.9 ng/dl). These results suggest a possible role for adrenal renin in the mechanism underlying the inhibitory effect of ANP on aldosterone production in vivo.

MeSH terms

  • Adrenal Glands / drug effects*
  • Adrenal Glands / metabolism
  • Adrenocorticotropic Hormone / pharmacology
  • Aldosterone / metabolism*
  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Male
  • Rats
  • Rats, Inbred Strains
  • Renin / metabolism*
  • Renin-Angiotensin System

Substances

  • Aldosterone
  • Atrial Natriuretic Factor
  • Adrenocorticotropic Hormone
  • Renin